Bilayered devices for enhanced healing

US11458042B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11458042-B2
Application numberUS-201615568767-A
CountryUS
Kind codeB2
Filing dateApr 25, 2016
Priority dateApr 23, 2015
Publication dateOct 4, 2022
Grant dateOct 4, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein is a multilayered wound dressing comprising a first layer; the first layer including channels that facilitate neovascularization of a wound; and a second layer in contact with the first layer, the second layer having the same or different chemical composition as the first layer; where the second layer comprises at least one surface that has a texture and the direction of the texture is operative to facilitate cell orientation and growth. A method includes forming a first layer of a polymeric material; forming a second layer of the same polymeric material as the first layer on the first layer; and forming a textured surface of the second layer of the same polymeric material as the first layer, the textured surface being operative to facilitate directional cell growth when used in a wound dressing, where the first layer and the second layer are formed using an additive manufacturing process.

First claim

Opening claim text (preview).

What is claimed is: 1. A multilayered wound dressing comprising: a first layer; the first layer comprising channels that facilitate neovascularization of a wound; wherein the first layer comprises a gel; and a second layer in direct contact with the first layer, the second layer having the same or different chemical composition as the first layer; wherein the second layer comprises at least one surface that has a texture that comprises a plurality of spaced features; wherein each feature has a substantially different geometry than a neighboring feature; the plurality of spaced features arranged in a plurality of groupings, the spaced features within each of the groupings being spaced apart at an average distance of about 10 nanometers to about 200 micrometers; the adjacent groupings of features being spaced from each other to define an intermediate tortuous pathway; wherein a direction of the texture is operative to facilitate cell orientation and growth and wherein the textured surface of the second layer does not contact the first layer. 2. The multilayer wound dressing of claim 1 , wherein the first layer comprises a surface that has a texture that is complementary to a patient's anatomy where the wound is located. 3. The multilayer wound dressing of claim 1 , wherein the first layer and the second layer are biodegradable layers. 4. The multilayer wound dressing of claim 1 , wherein the gel comprises a copper capillary alginate gel. 5. The multilayer wound dressing of claim 4 , wherein the copper capillary alginate gel is stabilized with barium ions. 6. The multilayer wound dressing of claim 4 , wherein the copper capillary alginate gel is stabilized using Cd 2+ , Cu 2+ , Ca 2+ , Ni 2+ , Co 2+ , and Mn 2+ . 7. The multilayer wound dressing of claim 1 , wherein the first layer and the second layer comprise polylactic-glycolic acid (PLGA), poly-caprolactone (PCL), copolymers of polylactic-glycolic acid and poly-caprolactone (PCL-PLGA copolymer), polyhydroxy-butyrate-valerate (PHBV), polyorthoester (POE), polyethylene oxide-butylene terephthalate (PEO-PBTP), poly-D,L-lactic acid-p-dioxanone-polyethylene glycol block copolymer (PLA-DX-PEG) or a combination comprising at least one of the foregoing polymers. 8. The multilayer wound dressing of claim 1 , wherein the first layer and the second layer comprise a copolymer of polyurethane and poly lactic acid or a copolymer of polyurethane and polylactic-glycolic acid.

Assignees

Inventors

Classifications

  • having more than one layer with different fluid retention characteristics · CPC title

  • Materials for use in artificial skin · CPC title

  • Porous materials, e.g. foams or sponges · CPC title

  • Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

  • Use of materials characterised by their function or physical properties (liquid bandages A61L26/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11458042B2 cover?
Disclosed herein is a multilayered wound dressing comprising a first layer; the first layer including channels that facilitate neovascularization of a wound; and a second layer in contact with the first layer, the second layer having the same or different chemical composition as the first layer; where the second layer comprises at least one surface that has a texture and the direction of the te…
Who is the assignee on this patent?
Univ Florida, Sharklet Tech Inc
What technology area does this patent fall under?
Primary CPC classification A61F13/00063. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).